<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104321">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02070861</url>
  </required_header>
  <id_info>
    <org_study_id>2013/1605</org_study_id>
    <nct_id>NCT02070861</nct_id>
  </id_info>
  <brief_title>Non-invasive Evaluation of Volume Status Using End-tidal CO2 and Pulse Contour Analysis</brief_title>
  <official_title>Non-invasive Volume Evaluation With Endtidal CO2 and Pulse Contour Analysis (Nexfin)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Norwegian Air Ambulance Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <authority>Norway: Regional Ethics Commitee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that exhaled CO2 reflect changes in blood circulation due to
      changes in lung circulation, provided CO2-production in the tissues and ventilation from the
      lungs are stable. The investigators want to investigate this in patients using different
      devices: a finger cuff measuring blood pressure and cardiac output (the amount of blood
      being pumped out of the heart each minute), an esophagus ultra sound device measuring
      cardiac output, and exhaled carbondioxide in the patients` breath measured by the
      ventilator.

      The investigators investigate patients undergoing bypass surgery on the heart, as they
      undergo relevant changes in blood circulation during their operation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Changes in cardiac output</measure>
    <time_frame>5 Minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Changes in Cardiac Output</condition>
  <arm_group>
    <arm_group_label>Endtidal CO2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One arm,</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Changes in cardiac output</intervention_name>
    <arm_group_label>Endtidal CO2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Persons 18 years or older scheduled to undergo arteriocoranary bypass surgery.

        Exclusion Criteria:

          -  Esophageal pathology
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ingrid Elise Hoff, MD</last_name>
    <phone>+4722119690</phone>
    <email>iehoff@yahoo.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oslo University Hospital, Ullev√•l</name>
      <address>
        <city>Oslo</city>
        <zip>0454</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ingrid Elise Hoff, MD</last_name>
      <phone>+4722119690</phone>
      <email>iehoff@yahoo.no</email>
    </contact>
    <investigator>
      <last_name>Ingrid Elise Hoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0876</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid Elise Hoff, MD</last_name>
      <phone>+4722118080</phone>
      <email>iehoff@yahoo.no</email>
    </contact>
    <investigator>
      <last_name>Ingrid Elise Hoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 14, 2014</lastchanged_date>
  <firstreceived_date>February 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Ingrid Elise Hoff</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Cardiac output</keyword>
  <keyword>Endtidal CO2</keyword>
  <keyword>Nexfin</keyword>
  <keyword>Esophageal Doppler</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
